
| Duration | Percentage |
|---|---|
| 1 week | 1.34 |
| 1 month | 3.05 |
| 6 months | 65.50 |
| 9 months | 119.83 |
| 1 year | 121.70 |
| Essentials | |
|---|---|
| Fund category | Equity - Sector Fund |
| Scheme plan | Growth |
| Scheme type | Open Ended |
| Launch date | June 05, 2004 |
| Fund manager | Mr. Sailesh Raj Bhan |
| Fund info | |
|---|---|
| AMC | Reliance Capital Asset Management Ltd. |
| Objective | The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies. |
| Asset (Rs crore) | 141.99 ( August 31, 2009) |
| Dividend (%) | 15.00 ( August 31, 2009) |
| Company | Percentage |
|---|---|
| Aventis Pharma Ltd. | 10.44 |
| Indoco Remedies | 8.84 |
| Torrent Pharmac | 8.44 |
| Zydus Wellness Ltd. | 8.22 |
| Fulford (India) | 7.46 |
| Aurobindo Pharma | 7.45 |
| Lupin Ltd. | 7.15 |
| Ranbaxy Labs. | 6.93 |
| Divi's Lab | 6.3 |
| GlaxoSmithKline Phar | 5.05 |
| Company | Percentage |
|---|---|
| Pharmaceuticals | 88.0 |
| Vanaspati | 8.0 |
| Hospitals & Medical Services | 2.0 |